Cyclosporin A promotes in vivo myogenic response in collagen VI-deficient myopathic mice

Frontiers in Aging Neuroscience

Volumn 6, Issue SEP, 2014, Pages

  Gattazzo, Francesca ^a,b   Molon, Sibilla ^a   Morbidoni, Valeria ^a   Braghetta, Paola ^a   Blaauw, Bert ^a   Urciuolo, Anna ^a,c   Bonaldo, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Animal model; Collagen VI; Congenital muscular dystrophy; Cyclosporin A; Muscle regeneration; Skeletal muscle

Indexed keywords

CARDIOTOXIN; COLLAGEN TYPE 6; CYCLOSPORIN A; MYOGENIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOPHAGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HISTOLOGY; IN VIVO STUDY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; SATELLITE CELL; TIBIALIS ANTERIOR MUSCLE; TURNER SYNDROME;

EID: 84907946308     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00244     Document Type: Article

References (30)

1. Angelin, A., Tiepolo, T., Sabatelli, P., Grumati, P., Bergamin, N., Golfieri, C., et al. (2007). Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc. Natl. Acad. Sci. U.S.A. 104, 991-996. doi: 10.1073/pnas.0610270104
2. Bonaldo, P., Braghetta, P., Zanetti, M., Piccolo, S., Volpin, D., and Bressan, G. M. (1998). Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum. Mol. Genet. 7, 2135-2140. doi:10.1093/hmg/7.13.2135
3. Buckingham, M., and Rigby, P. W. J. (2014). Gene regulatory networks and transcriptional mechanisms that control myogenesis. Dev. Cell 28, 225-238. doi:10.1016/j.devcel.2013.12.020
4. Chargé, S. B. P., and Rudnicki, M. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238. doi:10.1152/physrev.00019.2003
5. Ciciliot, S., and Schiaffino, S. (2010). Regeneration of mammalian skeletal muscle: basic mechanisms and clinical implications. Curr. Pharm. Des. 16, 906-914. doi:10.2174/138161210790883453
6. Couteaux, R., Mira, J. C., and D'Albis, A. (1988). Regeneration of muscles after cardiotoxin injury. I. Cytological aspects. Biol. Cell 62, 171-182. doi:10.1111/j.1768-322X.1988.tb00719.x
7. De Luca, A., Nico, B., Liantonio, A., Didonna, M. P., Fraysse, B., Pierno, S., et al. (2005). A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. Am. J. Pathol. 166, 477-489. doi:10.1016/S0002-9440(10)62270-5
8. Dunn, S. E., Simard, A. R., Prud'homme, R. A., and Michel, R. N. (2002). Calcineurin and skeletal muscle growth. Nat. Cell Biol. 4, E46. doi:10.1038/ncb0302-e46a author reply E46-47
9. Grumati, P., Coletto, L., Sabatelli, P., Cescon, M., Angelin, A., Bertaggia, E., et al. (2010). Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 16, 1313-1320. doi:10.1038/nm.2247
10. Hawke, T. J., Meeson, A. P., Jiang, N., Graham, S., Hutcheson, K., DiMaio, J. M., et al. (2003). p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. Am. J. Physiol. Cell Physiol. 285, C1019-C1027. doi:10.1152/ajpcell.00055.2003
11. Homan, W. P., Fabre, J. W., Williams, K. A., Millard, P. R., and Morris, P. J. (1980). Studies on the immunosuppressive properties of cyclosporin A in rats receiving renal allografts. Transplantation 29, 361-366. doi:10.1097/00007890-198005000-00003
12. Hudson, M. B., and Price, S. R. (2013). Calcineurin: a poorly understood regulator of muscle mass. Int. J. Biochem. Cell Biol. 45, 2173-2178. doi:10.1016/j.biocel.2013.06.029
13. Hunt, J., Cheng, A., Hoyles, A., Jervis, E., and Morshead, C. M. (2010). Cyclosporin A has direct effects on adult neural precursor cells. J. Neurosci. 30, 2888-2896. doi:10.1523/JNEUROSCI.5991-09.2010
14. Irwin, W. A., Bergamin, N., Sabatelli, P., Reggiani, C., Megighian, A., Merlini, L., et al. (2003). Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat. Genet. 35, 367-371. doi:10.1038/ng1270
15. Lampe, A. K., and Bushby, K. M. D. (2005). Collagen VI related muscle disorders. J. Med. Genet. 42, 673-685. doi:10.1136/jmg.2002.002311
16. Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815. doi:10.1016/0092-8674(91)90124-H
17. Merlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., et al. (2008). Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc. Natl. Acad. Sci. U.S.A. 105, 5225-5229. doi:10.1073/pnas.0800962105
18. Merlini, L., Sabatelli, P., Armaroli, A., Gnudi, S., Angelin, A., Grumati, P., et al. (2011). Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results. Oxid. Med. Cell. Longev. 2011, 139194. doi:10.1155/2011/139194
19. Michel, R. N., Dunn, S. E., and Chin, E. R. (2004). Calcineurin and skeletal muscle growth. Proc. Nutr. Soc. 63, 341-349. doi:10.1079/PNS2004362
20. Parsons, S. A., Millay, D. P., Sargent, M. A., Naya, F. J., McNally, E. M., Sweeney, H. L., et al. (2007). Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy. J. Biol. Chem. 282, 10068-10078. doi:10.1074/jbc.M609368200
21. Sakuma, K., Nakao, R., Aoi, W., Inashima, S., Fujikawa, T., Hirata, M., et al. (2005). Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration. Acta Neuropathol. 110, 269-280. doi:10.1007/s00401-005-1049-x
22. Sakuma, K., Nishikawa, J., Nakao, R., Watanabe, K., Totsuka, T., Nakano, H., et al. (2003). Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol. 105, 271-280. doi:10.1007/s00401-002-0647-0
23. Sakuma, K., and Yamaguchi, A. (2010). The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle. J. Biomed. Biotechnol. 2010, 721219. doi:10.1155/2010/721219
24. Schiaffino, S., and Serrano, A. L. (2002). Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol. Sci. 6147, 569-575. doi:10.1016/S0165-6147(02)02111-9
25. Serrano, A. L., Mann, C. J., Vidal, B., Ardite, E., Perdiguero, E., and Muñoz-Cánoves, P. (2011). Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr. Top. Dev. Biol. 96, 167-201. doi:10.1016/B978-0-12-385940-2.00007-3
26. Shi, X., and Garry, D. J. (2006). Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692-1708. doi:10.1101/gad.1419406
27. Stupka, N., Gregorevic, P., Plant, D. R., and Lynch, G. S. (2004). The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Acta Neuropathol. 107, 299-310. doi:10.1007/s00401-003-0807-x
28. Tedesco, F. S., Dellavalle, A., Diaz-Manera, J., Messina, G., and Cossu, G. (2010). Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J. Clin. Invest. 120, 11-19. doi:10.1172/JCI40373
29. Urciuolo, A., Quarta, M., Morbidoni, V., Gattazzo, F., Molon, S., Grumati, P., et al. (2013). Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat. Commun. 4, 1964. doi:10.1038/ncomms2964
30. Zulian, A., Rizzo, E., Schiavone, M., Palma, E., Tagliavini, F., Blaauw, B., et al. (2014). NIM811, a cyclophilin inhibitor without immunosuppressive activity, is beneficial in collagen VI congenital muscular dystrophy models. Hum. Mol. Genet. doi:10.1093/hmg/ddu254